The Medicines and Healthcare products Regulatory Agency (MHRA) has approved Valneva’s single-dose chikungunya vaccine for use ...

H.C. Wainwright reaffirmed its Buy rating and $18.00 price target for Valneva (EPA:VLS) SE (NASDAQ:VALN) shares, following the recent approval of the company's Ixchiq vaccine in the United Kingdom ...

A second type of bird flu H5N1 has been detected in US cattle Some experts believe the risk for humans is low Infections have also been detected outside the US, in the United Kingdom European authorit ...

NTDs, a group of 21 debilitating infectious diseases, affect over 1 billion people globally, causing significant morbidity, disability, and death. These diseases, including visceral leishmaniasis (VL) ...

GBS, a neurological condition triggered by an overactive immune system often after viral or bacterial infections, has been ...

In a report released on February 5, Justine Telliez from Kepler Capital maintained a Buy rating on Valneva (0OB3 – Research Report), with a ...

The company expects 2025 adjusted profit to be in the range of $8.15 to $8.35 per share, compared with the average of ...

Flies circulating in hospital wards may pose a threat to vulnerable patients by spreading bacteria that are resistant to ...